Dose-Response (May 2022)

A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma

  • Qingtao Ni,
  • Chi Pan,
  • Qing Guo,
  • Peng Wang,
  • Yan Yang,
  • Wei Zhang,
  • Shengbin Dai

DOI
https://doi.org/10.1177/15593258221103373
Journal volume & issue
Vol. 20

Abstract

Read online

Lung squamous cell cancer (SCC) and accounts for approximately 20%–30% of all lung cancers. Surgery, chemotherapy and radiotherapy are the main treatments for lung SCC patients. A case with lung SCC patient who was treated using iodine 125 seeds (I-125) because the location of the tumor was adjacent to the great vessels. I-125 is an ideal brachytherapy for lung SCC patients with large masses who lost the chance of operation. I-125 is an adjuvant therapy, combined with chemotherapy and molecular targeting therapy might serve to improve the prognosis of lung SCC patients.